8th German Pharm-Tox Summit

Voriconazole clearance can be predicted by CYP3A and CYP2C19 activity using microdosed probe drugs

Pharmacokinetics and PK/PD modelling	

Drug transport, metabolism and pharmacogenomics 

Oral presentation

PANHPVAX: Study design for dose titration of two first-in-human molecules (human papillomavirus L2 antigen with cyclic di-AMP) in a single vaccine trial

Disease models, drug development

<B>Posters will be presented during the time period mentioned above. This will give all participants and the poster jury the opportunity to interact with the presenting authors. Please be available to answer questions at your poster during the poster session.  

Session 1

Poster

Immunopharmacology / inflammation / anti-infectives	

PD Dr.

Antje Blank

Weitere Beteiligungen